Oxitope Pharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

Oxitope Pharma General Information

Description

Developer of antibody and gene therapy products intended to treat inflammatory and cardiovascular diseases. The company's products utilize innovative therapeutic approaches, focusing on enhancing the effectiveness of treatments while minimizing side effects, enabling healthcare providers to improve patient outcomes and offering a more targeted approach to cancer therapy.

Contact Information

Website
www.oxitopepharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Calluna Pharma
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxitope Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 22-Jan-2024 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) Cancelled Pre-Clinical Trials
3. Grant 26-Oct-2021 Completed Pre-Clinical Trials
2. Seed Round 20-Aug-2021 $2.72M $2.72M Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2020 Completed Pre-Clinical Trials
To view Oxitope Pharma’s complete valuation and funding history, request access »

Oxitope Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxitope Pharma Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eurostars Other Minority
Forbion Venture Capital Minority
University of California, San Diego University
To view Oxitope Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Oxitope Pharma FAQs

  • When was Oxitope Pharma founded?

    Oxitope Pharma was founded in 2020.

  • Where is Oxitope Pharma headquartered?

    Oxitope Pharma is headquartered in Naarden, Netherlands.

  • What is the size of Oxitope Pharma?

    Oxitope Pharma has 6 total employees.

  • What industry is Oxitope Pharma in?

    Oxitope Pharma’s primary industry is Drug Discovery.

  • Is Oxitope Pharma a private or public company?

    Oxitope Pharma is a Private company.

  • What is Oxitope Pharma’s current revenue?

    The current revenue for Oxitope Pharma is .

  • How much funding has Oxitope Pharma raised over time?

    Oxitope Pharma has raised $2.72M.

  • Who are Oxitope Pharma’s investors?

    Eurostars, Forbion, and University of California, San Diego have invested in Oxitope Pharma.

  • When was Oxitope Pharma acquired?

    Oxitope Pharma was acquired on 22-Jan-2024.

  • Who acquired Oxitope Pharma?

    Oxitope Pharma was acquired by Calluna Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process